Taken together, our results suggest that the latently infected
HIV-1 virus might design an impaired T cell activation strategy in
part of IL-2 production, enabling it to evade the host's immune
surveillance. This finding may help to advanced research focusing
on the investigation of potential therapeutic targets for this HIV-1
reservoir